Senescent CD153+ T Lymphocytes Increase in the Peripheral Blood of Patients with Thromboangiitis Obliterans.

CD57 CD153/CD30L Cigarette Smoking Immunosenescence Thromboangiitis Obliterans

Journal

Iranian journal of immunology : IJI
ISSN: 1735-367X
Titre abrégé: Iran J Immunol
Pays: Iran
ID NLM: 101282932

Informations de publication

Date de publication:
01 09 2023
Historique:
medline: 30 8 2023
pubmed: 30 8 2023
entrez: 30 8 2023
Statut: ppublish

Résumé

Buerger's disease, also known as Thromboangiitis Obliterans (TAO), is a progressive, inflammatory vascular disease with unknown etiology. To address the degree of T cell immunosenescence in this inflammatory disease, the frequency of senescent T cells expressing CD57 and/or CD153 (CD30L) in patients with TAO. In this study, nine male cigarette smoker patients with TAO, nine male healthy cigarette smokers, and nine male healthy non-smoker blood donors were enrolled. PBMCs were extracted from the blood of all participants and stored in liquid nitrogen before use. The percentages of senescent T cells were detected by flow cytometry. The results were analyzed using non-parametric statistical tests. The frequencies of senescent CD3+CD4+CD57+CD153+ and CD3+CD4+CD57-CD153+ T cells significantly increased in patients compared with the non-smoker controls (p=0.01 and p=0.04, respectively). The frequency of senescent CD3+CD4-CD57-CD153+ T cells was higher in patients compared with the smoker controls (p=0.02). In patients with TAO, CD57+CD153- cells were more frequent in CD3hiCD4- and CD3hiCD4+ T cells compared with the CD3loCD4- and CD3loCD4+ T cells (p=0.008 and p=0.0002, respectively). Conversely, the frequency of CD57-CD153+ T cells was significantly higher in CD3loCD4- T cells compared with the CD3hiCD4- T cells (p=0.004). The percentage of CD3+CD4+CD57+CD153- T cells correlated negatively with smoking level in smoker controls (p=0.02, Spearman r=-0.80). Elevated frequencies of senescent CD4+CD57+CD153+ and CD4+CD57-CD153+ T cells in patients compared with non-smoker and smoker controls suggest the contribution of immunosenescence in TAO.

Sections du résumé

Background
Buerger's disease, also known as Thromboangiitis Obliterans (TAO), is a progressive, inflammatory vascular disease with unknown etiology.
Objective
To address the degree of T cell immunosenescence in this inflammatory disease, the frequency of senescent T cells expressing CD57 and/or CD153 (CD30L) in patients with TAO.
Methods
In this study, nine male cigarette smoker patients with TAO, nine male healthy cigarette smokers, and nine male healthy non-smoker blood donors were enrolled. PBMCs were extracted from the blood of all participants and stored in liquid nitrogen before use. The percentages of senescent T cells were detected by flow cytometry. The results were analyzed using non-parametric statistical tests.
Results
The frequencies of senescent CD3+CD4+CD57+CD153+ and CD3+CD4+CD57-CD153+ T cells significantly increased in patients compared with the non-smoker controls (p=0.01 and p=0.04, respectively). The frequency of senescent CD3+CD4-CD57-CD153+ T cells was higher in patients compared with the smoker controls (p=0.02). In patients with TAO, CD57+CD153- cells were more frequent in CD3hiCD4- and CD3hiCD4+ T cells compared with the CD3loCD4- and CD3loCD4+ T cells (p=0.008 and p=0.0002, respectively). Conversely, the frequency of CD57-CD153+ T cells was significantly higher in CD3loCD4- T cells compared with the CD3hiCD4- T cells (p=0.004). The percentage of CD3+CD4+CD57+CD153- T cells correlated negatively with smoking level in smoker controls (p=0.02, Spearman r=-0.80).
Conclusion
Elevated frequencies of senescent CD4+CD57+CD153+ and CD4+CD57-CD153+ T cells in patients compared with non-smoker and smoker controls suggest the contribution of immunosenescence in TAO.

Identifiants

pubmed: 37647581
doi: 10.22034/iji.2023.99188.2622
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

262-275

Auteurs

Niloofar Mashhadi (N)

Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Leila Kasraian (L)

Blood Transfusion Research Center, High Institute for Education and Research, Shiraz, Iran.

Hamed Ghoddusi Johari (H)

Department of Surgery, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Ahmad Hosseinzadeh (A)

Department of Surgery, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Nasim Kheshtchin (N)

Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Mehrnoosh Doroudchi (M)

Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Immunology Center for Excellence, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Classifications MeSH